Alkaline-extracted influenza subunit vaccine.
Identifieur interne : 002B10 ( Main/Exploration ); précédent : 002B09; suivant : 002B11Alkaline-extracted influenza subunit vaccine.
Auteurs : E A EckertSource :
- Infection and Immunity [ 0019-9567 ] ; 1976.
Abstract
Treatment of influenza virus concentrates with alkaline solvents releases a major fraction of the viral structural protein content. As determined by polyacrylamide gel electrophoresis, the surface glycoprotein substructures, hemagglutinin and neuraminidase, are the primary solubilized products. Two forms of hemagglutinin antigen are recovered, a 39S active hemagglutinin and a 23S blocking antigen. Dose-response assays in mice demonstrate that hemagglutination-inhibiting and neuraminidase antibodies are induced. Antibody responses are comparable to those resulting from immunization with inactivated whole virus. On the basis of demonstrated purity, high yields of protective antigens, immunogenic potency, and absence of deleterious reagents, alkaline-extracted influenza protein preparations merit consideration as subunit vaccines for human use.
Url:
PubMed: 826484
PubMed Central: 415532
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: 000325
- to stream Pmc, to step Curation: 000325
- to stream Pmc, to step Checkpoint: 000E24
- to stream Ncbi, to step Merge: 001311
- to stream Ncbi, to step Curation: 001311
- to stream Ncbi, to step Checkpoint: 001311
- to stream Main, to step Merge: 002C80
- to stream Main, to step Curation: 002B10
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Alkaline-extracted influenza subunit vaccine.</title><author><name sortKey="Eckert, E A" sort="Eckert, E A" uniqKey="Eckert E" first="E A" last="Eckert">E A Eckert</name></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">826484</idno><idno type="pmc">415532</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC415532</idno><idno type="RBID">PMC:415532</idno><date when="1976">1976</date><idno type="wicri:Area/Pmc/Corpus">000325</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000325</idno><idno type="wicri:Area/Pmc/Curation">000325</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000325</idno><idno type="wicri:Area/Pmc/Checkpoint">000E24</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000E24</idno><idno type="wicri:Area/Ncbi/Merge">001311</idno><idno type="wicri:Area/Ncbi/Curation">001311</idno><idno type="wicri:Area/Ncbi/Checkpoint">001311</idno><idno type="wicri:doubleKey">0019-9567:1976:Eckert E:alkaline:extracted:influenza</idno><idno type="wicri:Area/Main/Merge">002C80</idno><idno type="wicri:Area/Main/Curation">002B10</idno><idno type="wicri:Area/Main/Exploration">002B10</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Alkaline-extracted influenza subunit vaccine.</title><author><name sortKey="Eckert, E A" sort="Eckert, E A" uniqKey="Eckert E" first="E A" last="Eckert">E A Eckert</name></author></analytic><series><title level="j">Infection and Immunity</title><idno type="ISSN">0019-9567</idno><idno type="eISSN">1098-5522</idno><imprint><date when="1976">1976</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p>Treatment of influenza virus concentrates with alkaline solvents releases a major fraction of the viral structural protein content. As determined by polyacrylamide gel electrophoresis, the surface glycoprotein substructures, hemagglutinin and neuraminidase, are the primary solubilized products. Two forms of hemagglutinin antigen are recovered, a 39S active hemagglutinin and a 23S blocking antigen. Dose-response assays in mice demonstrate that hemagglutination-inhibiting and neuraminidase antibodies are induced. Antibody responses are comparable to those resulting from immunization with inactivated whole virus. On the basis of demonstrated purity, high yields of protective antigens, immunogenic potency, and absence of deleterious reagents, alkaline-extracted influenza protein preparations merit consideration as subunit vaccines for human use.</p></div></front></TEI><affiliations><list></list><tree><noCountry><name sortKey="Eckert, E A" sort="Eckert, E A" uniqKey="Eckert E" first="E A" last="Eckert">E A Eckert</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002B10 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002B10 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= H2N2V1
|flux= Main
|étape= Exploration
|type= RBID
|clé= PMC:415532
|texte= Alkaline-extracted influenza subunit vaccine.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:826484" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a H2N2V1
| This area was generated with Dilib version V0.6.33. |  |